Literature DB >> 25085258

Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?

Geoffrey D Wool1, Catherine A Reardon2, Godfrey S Getz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25085258      PMCID： PMC4173990          DOI： 10.1194/jlr.E053538

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  24 in total

1.  CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.

Authors:  Claudine Tardy; Marine Goffinet; Nadia Boubekeur; Rose Ackermann; Gavin Sy; Alice Bluteau; Guy Cholez; Constance Keyserling; Narendra Lalwani; John F Paolini; Jean-Louis Dasseux; Ronald Barbaras; Rudi Baron
Journal:  Atherosclerosis       Date:  2013-11-08       Impact factor: 5.162

2.  5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

Authors:  Marcelo J A Amar; Wilissa D'Souza; Scott Turner; Stephen Demosky; Denis Sviridov; John Stonik; Jayraz Luchoomun; Jason Voogt; Marc Hellerstein; Dmitri Sviridov; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2010-05-19       Impact factor: 4.030

3.  Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.

Authors:  Mohamad Navab; Srinivasa T Reddy; G M Anantharamaiah; Satoshi Imaizumi; Greg Hough; Susan Hama; Alan M Fogelman
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

4.  An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.

Authors:  I R Nikoulin; L K Curtiss
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 5.  Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.

Authors:  G M Anantharamaiah; Vinod K Mishra; David W Garber; Geeta Datta; Shaila P Handattu; Mayakonda N Palgunachari; Manjula Chaddha; Mohamad Navab; Srinivasa T Reddy; Jere P Segrest; Alan M Fogelman
Journal:  J Lipid Res       Date:  2007-06-14       Impact factor: 5.922

6.  Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.

Authors:  Shaila P Handattu; Gaurav Nayyar; David W Garber; Mayakonda N Palgunachari; Candyce E Monroe; Tamara D Keenum; Vinod K Mishra; Geeta Datta; G M Anantharamaiah
Journal:  Atherosclerosis       Date:  2012-11-02       Impact factor: 5.162

7.  A novel approach to oral apoA-I mimetic therapy.

Authors:  Arnab Chattopadhyay; Mohamad Navab; Greg Hough; Feng Gao; David Meriwether; Victor Grijalva; James R Springstead; Mayakonda N Palgnachari; Ryan Namiri-Kalantari; Feng Su; Brian J Van Lenten; Alan C Wagner; G M Anantharamaiah; Robin Farias-Eisner; Robin Farias-Eisener; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2013-02-02       Impact factor: 5.922

8.  An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.

Authors:  Geoffrey D Wool; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2009-05-11       Impact factor: 5.922

9.  Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid.

Authors:  Mohamad Navab; Greg Hough; Georgette M Buga; Feng Su; Alan C Wagner; David Meriwether; Arnab Chattopadhyay; Feng Gao; Victor Grijalva; Janet S Danciger; Brian J Van Lenten; Elin Org; Aldons J Lusis; Calvin Pan; G M Anantharamaiah; Robin Farias-Eisner; Susan S Smyth; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2013-10-01       Impact factor: 5.922

10.  Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.

Authors:  Geoffrey D Wool; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-03-05       Impact factor: 5.922
View more
  6 in total

Review 1.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review.

Authors:  C Roger White; David W Garber; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2014-08-25       Impact factor: 5.922

2.  Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.

Authors:  Mohamad Navab; Arnab Chattopadhyay; Greg Hough; David Meriwether; Spencer I Fogelman; Alan C Wagner; Victor Grijalva; Feng Su; G M Anantharamaiah; Lin H Hwang; Kym F Faull; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2015-02-02       Impact factor: 5.922

3.  A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE-/- mice.

Authors:  Sanhu Gou; Li Wang; Chao Zhong; Xinyue Chen; Xu Ouyang; Beibei Li; Guangjun Bao; Hui Liu; Yun Zhang; Jingman Ni
Journal:  Br J Pharmacol       Date:  2020-09-09       Impact factor: 8.739

4.  Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.

Authors:  Richard L Dunbar; Rajesh Movva; LeAnne T Bloedon; Danielle Duffy; Robert B Norris; Mohamad Navab; Alan M Fogelman; Daniel J Rader
Journal:  Clin Transl Sci       Date:  2017-08-09       Impact factor: 4.689

5.  Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation.

Authors:  Pallavi Mukherjee; Arnab Chattopadhyay; Victor Grijalva; Nasrin Dorreh; Venu Lagishetty; Jonathan P Jacobs; Bethan L Clifford; Thomas Vallim; Julia J Mack; Mohamad Navab; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2021-11-20       Impact factor: 5.922

6.  Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer.

Authors:  Arnab Chattopadhyay; Xinying Yang; Pallavi Mukherjee; Dawoud Sulaiman; Hannah R Fogelman; Victor Grijalva; Steven Dubinett; Tonya C Wasler; Manash K Paul; Ramin Salehi-Rad; Julia J Mack; M Luisa Iruela-Arispe; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.